5-10-methylenetetrahydrofolic-acid has been researched along with Muscle-Spasticity* in 2 studies
2 other study(ies) available for 5-10-methylenetetrahydrofolic-acid and Muscle-Spasticity
Article | Year |
---|---|
Functional characterization of missense mutations in severe methylenetetrahydrofolate reductase deficiency using a human expression system.
5,10-Methylenetetrahydrofolate reductase (MTHFR) catalyzes the NADPH-dependent reduction of 5,10-methylenetetrahydrofolate to 5-methyltetrahydrofolate using FAD as the cofactor. Severe MTHFR deficiency is the most common inborn error of folate metabolism, resulting in hyperhomocysteinemia and homocystinuria. Approximately 70 missense mutations have been described that cause severe MTHFR deficiency, however, in most cases their mechanism of dysfunction remains unclear. Few studies have investigated mutational specific defects; most of these assessing only activity levels from a handful of mutations using heterologous expression. Here, we report the in vitro expression of 22 severe MTHFR missense mutations and two known single nucleotide polymorphisms (p.Ala222Val, p.Thr653Met) in human fibroblasts. Significant reduction of MTHFR activity (<20 % of wild-type) was observed for five mutant proteins that also had highly reduced protein levels on Western blot analysis. The remaining mutations produced a spectrum of enzyme activity levels ranging from 22-122 % of wild-type, while the SNPs retained wild-type-like activity levels. We found increased thermolability for p.Ala222Val and seven disease-causing mutations all located in the catalytic domain, three of which also showed FAD responsiveness in vitro. By contrast, six regulatory domain mutations and two mutations clustering around the linker region showed increased thermostability compared to wild-type protein. Finally, we confirmed decreased affinity for NADPH in individual mutant enzymes, a result previously described in primary patient fibroblasts. Our expression study allows determination of significance of missense mutations in causing deleterious loss of MTHFR protein and activity, and is valuable in detection of aberrant kinetic parameters, but should not replace investigations in native material. Topics: Amino Acid Metabolism, Inborn Errors; Catalytic Domain; Fibroblasts; Genotype; Homocystinuria; Humans; Hyperhomocysteinemia; Kinetics; Methylenetetrahydrofolate Reductase (NADPH2); Muscle Spasticity; Mutant Proteins; Mutation, Missense; NADP; Polymorphism, Single Nucleotide; Psychotic Disorders; Tetrahydrofolates | 2017 |
5,10-Methylenetetrahydrofolate reductase deficiency with progressive polyneuropathy in an infant.
5,10-Methylenetetrahydrofolate reductase (MTHFR) deficiency is the most prevalent inborn error of folate metabolism, and has variable clinical manifestations from asymptomatic to severe psychomotor retardation, microcephalus and seizure. In untreated infantile cases, it predominantly affects the central nervous system, which is sometimes fatal. On the other hand, peripheral nerve involvement is uncommon. We present a severe infantile case of MTHFR deficiency that manifested unilateral phrenic nerve palsy with communicating hydrocephalus, developmental delay and died at 11months of age. An enzymatic study confirmed MTHFR deficiency with residual activity of 0.75% of mean control values in cultured fibroblasts. Mutation analysis of the MTHFR gene revealed homozygous, tandem missense mutations c.[446G>T; 447C>T] in exon 3 of the MTHFR gene converting glycine to valine (Gly149Val). In MTHFR deficiency, betaine may improve the symptoms if started immediately after birth by reducing the level of serum homocysteine and increasing that of methionine. Our results show that we should be aware of possible inborn errors of folate metabolism such as MTHFR deficiency, in infants with unexplained developmental delay manifesting rapidly progressive polyneuropathy. Topics: Amino Acid Sequence; Animals; Asian People; Brain; Homocystinuria; Humans; Infant; Magnetic Resonance Imaging; Methylenetetrahydrofolate Reductase (NADPH2); Molecular Sequence Data; Muscle Spasticity; Mutation, Missense; Polyneuropathies; Psychotic Disorders; Sequence Alignment; Tetrahydrofolates | 2011 |